Patent · US Active

Tetrahydropyridopyrazine modulators of GPR6

US10406157B2 · kind B2 · utility

0Cited by

5References

28Claims

0Family size

Assignee

Takeda Pharmaceutical Company Limited · JP

Inventors

Jason W. Brown · San Diego, US
Stephen Hitchcock · San Diego, US
Maria Hopkins · San Diego, US
Shota Kikuchi · San Diego, US
Holger Monenschein · San Diego, US
Holly Reichard · San Diego, US
Kristin Schleicher · San Diego, US
Huikai Sun · San Diego, US
Todd Macklin · San Diego, US

Key dates

Filing date	Jun 15, 2018
Grant date	Sep 10, 2019
Priority date	—
Expiry date	Jun 15, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a compound of Formula 1, and a pharmaceutically acceptable salt thereof. This disclosure also relates to materials and methods for preparing the compound of Formula 1, to pharmaceutical compositions which contain it, and to its use for treating diseases, disorders, and conditions associated with GPR6.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.